NEW YORK (GenomeWeb News) – Life science investment firm MPM Capital's SunStates Fund has acquired a minority stake in InformedDNA with a $3 million investment, the genetic counseling and genetic benefits management services firm announced today.

The investment will be used by InformedDNA to expand its genetic benefits utilization management offerings and to develop new specialty genetic services for the drug manufacturing sector, the St. Petersburg, Fla.-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.